Coltalin-dm Tablet
NDC Package 51467-007-01
Package Information
Coltalin-dm (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrobromide, phenylephrine hydrochloride) tablets is classified as a
- adrenergic alpha1-agonists - [moa] (mechanism of action)
- histamine h1 receptor antagonists - [moa] (mechanism of action)
- histamine-1 receptor antagonist - [epc] (established pharmacologic class)
- sigma-1 agonist - [epc] (established pharmacologic class)
- sigma-1 receptor agonists - [moa] (mechanism of action)
- uncompetitive n-methyl-d-aspartate receptor antagonist - [epc] (established pharmacologic class)
- uncompetitive nmda receptor antagonists - [moa] (mechanism of action)
- alpha-1 adrenergic agonist - [epc] (established pharmacologic class)
Identification & Billing
- RxCUI: 1086991 - acetaminophen 325 MG / chlorpheniramine maleate 2 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG Oral Tablet
- RxCUI: 1086991 - acetaminophen 325 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG Oral Tablet
- RxCUI: 1086991 - APAP 325 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG Oral Tablet
Clinical Specifications
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Histamine H1 Receptor Antagonists - [MoA] (Mechanism of Action)
- Histamine-1 Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 51467 - Fortune Pharmacal Company Limited
- 51467-007 - Coltalin-dm
- 51467-007-01 - 2 BLISTER PACK in 1 BOX / 12 TABLET in 1 BLISTER PACK
- 51467-007 - Coltalin-dm
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (51467-007). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51467-007-01 identifies a specific commercial package of 2 blister pack in 1 box / 12 tablet in 1 blister pack of Coltalin-dm, a human over the counter drug labeled by Fortune Pharmacal Company Limited. This tablet is formulated for oral use and contains acetaminophen; chlorpheniramine maleate; dextromethorphan hydrobromide; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Fortune Pharmacal Company Limited on January 30, 2026. The current certification is valid through December 31, 2027.
How is this Fortune Pharmacal Company Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51467000701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.